Trexquant Investment LP - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 128 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.94 and the average weighting 0.8%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$92,000
+37.3%
14,563
+43.9%
0.01%
+100.0%
Q4 2018$67,000
-64.2%
10,117
-42.1%
0.00%
-71.4%
Q3 2018$187,000
-20.8%
17,481
-11.2%
0.01%
-12.5%
Q2 2018$236,000
+33.3%
19,676
-4.9%
0.02%
+33.3%
Q1 2018$177,000
-45.2%
20,683
-8.2%
0.01%
-70.7%
Q1 2017$323,00022,5350.04%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$34,786,00099.98%
Artal Group S.A. 57,517,978$463,019,00019.93%
MASTERS CAPITAL MANAGEMENT LLC 1,129,708$9,094,0000.30%
Rhenman & Partners Asset Management AB 170,915$1,376,0000.16%
Round Table Services, LLC 21,611$174,0000.14%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$287,0000.10%
FALCON POINT CAPITAL, LLC 37,039$298,0000.10%
SABBY MANAGEMENT, LLC 318,775$2,566,0000.09%
WILLIAM HARRIS INVESTORS INC 39,495$318,0000.09%
HOWARD HUGHES MEDICAL INSTITUTE 51,520$415,0000.09%
View complete list of LEXICON PHARMACEUTICALS INC shareholders